TNFα and IL-1β exert no direct vasoactivity in human isolated resistance arteries

Cytokine

Volumn 20, Issue 5, 2002, Pages 244-246

  Pickkers, Peter ^a   Netea, Mihai G ^a   Van Der Meer, Jos W M ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arteries; Cytokines; Human; Sepsis; Vasoactivity

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; NORADRENALIN; POTASSIUM; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ARTERY; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; HUMAN; HUMAN TISSUE; MYOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; RESISTANCE BLOOD VESSEL; VASOMOTOR REFLEX; DRUG EFFECT;

ANIMALIA;

ARTERIES; HUMANS; INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0042306322     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2002.2004     Document Type: Article

References (15)

1. Wilson F. Surgical intensive care units. Parillo J.E., Ayres S.M. Major Issues in Critical Care Medicine. 1984;17-33 Williams & WilkinsBaltimore.
2. Parillo J.E., Parker M.M., Natanson C., Suffredine A.F., Danner R.L., Cunnion R.E., Ognibene F.P. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 113:1990;227-242.
3. Van der Poll T., Lowry S.F. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock. 3:1995;1-12.
4. Dinarello C.A. Biological basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
5. Schirmer W.J., Schirmer J.M., Fry D.E. Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg. 124:1989;445-448.
6. Natanson C., Eichenholz P.W., Danner R.L., Eichacker P.Q., Hoffman W.D., Kou G.C., Banks S.M., Macvittie T.J., Parillo J.E. Endotoxin and tumor necrosis factor challenges in dogs stimulate the cardiovascular profile of human septic shock. J Exp Med. 169:1989;823-832.
7. Beasley D., Schwartz J.H., Brenner B.M. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest. 87:1991;602-608.
8. + channel opening to the Interleukin-1β-induced inhibition of vascular smooth muscle contraction. J Vet Med Sci. 61:1999;357-360.
9. B receptor-mediated contraction. Eur J Pharmacol. 376:1999;223-232.
10. B receptor-mediated contraction in human temporal artery. Eur J Pharmacol. 406:2000;117-122.
11. Marceau F., Petitclerc E., De Blois D., Pradelles P., Poubelle P.E. Human interleukin-1 induces a rapid relaxation of the rabbit isolated mesenteric artery. Br J Pharmacol. 103:1991;1367-1372.
12. Hollenberg S.M., Cunnion R.E., Parillo J.E. The effect of tumor necrosis factor on vascular smooth muscle. Chest. 100:1991;1133-1137.
13. Szabo C., Mitchell J.A., Thiemermann C., Vane J.R. Nitri oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol. 108:1993;786-792.
14. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 41:1977;19-26.
15. Cannon J.G., Tompkins R.G., Gelfand J.A., Michie H.R., Stanford G.G., van der Meer J.W., Endres S., Lonnemann G., Corsetti J., Chernow B., Wilmore D.W., Wolff S.M., Burke J.F., Dinarello C.A. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 161:1990;79-84.